BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Langner J, Schramm G, Laniado M, Kotzerke J, van den Hoff J. PET/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging 2013;40:6-11. [PMID: 23053322 DOI: 10.1007/s00259-012-2248-z] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Murtojärvi S, Malaspina S, Kinnunen I, Tuokkola T, Honka M, Saunavaara V, Tolvanen T, Schrey A, Kemppainen J, Filippi L. Diagnostic Accuracy of 18F-FDG-PET/CT and 18F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI. Contrast Media & Molecular Imaging 2022;2022:1-13. [DOI: 10.1155/2022/8676787] [Reference Citation Analysis]
2 Gong J, Liu H, Bao Z, Bian L, Li X, Meng Y. Relative clinical utility of simultaneous 18F-fluorodeoxyglucose PET/MRI and PET/CT for preoperative cervical cancer diagnosis. J Int Med Res 2021;49:3000605211019190. [PMID: 34162259 DOI: 10.1177/03000605211019190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Li H, Chen X, Zhang Y, Wang K, Gao Z. Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels. Cancer Manag Res 2021;13:2869-76. [PMID: 33824601 DOI: 10.2147/CMAR.S293005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Crimì F, Borsetto D, Stramare R, Di Carlo R, Emauelli E, Nicolai P, Lacognata C, Zucchetta P, Oliveri G, Merola A, Bodanza V, Albertoni L, Campi C, Cecchin D. [18F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases. Ann Nucl Med 2021;35:260-9. [PMID: 33454923 DOI: 10.1007/s12149-020-01565-5] [Reference Citation Analysis]
5 Pyatigorskaya N, De Laroche R, Bera G, Giron A, Bertolus C, Herve G, Chambenois E, Bergeret S, Dormont D, Amor-Sahli M, Kas A. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous 18F-FDG-PET/MRI for Tumor Delineation in Head and Neck Cancer? AJNR Am J Neuroradiol 2020;41:1888-96. [PMID: 32972956 DOI: 10.3174/ajnr.A6764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Freihat O, Pinter T, Kedves A, Sipos D, Cselik Z, Repa I, Kovács Á. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Cancer Imaging 2020;20:56. [PMID: 32771060 DOI: 10.1186/s40644-020-00334-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Park J, Pak K, Yun TJ, Lee EK, Ryoo I, Lee JY, Hwang I, Yoo RE, Kang KM, Choi SH, Sohn CH, Cheon GJ, Kim JH. Diagnostic Accuracy and Confidence of [18F] FDG PET/MRI in comparison with PET or MRI alone in Head and Neck Cancer. Sci Rep 2020;10:9490. [PMID: 32528161 DOI: 10.1038/s41598-020-66506-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dang H, Chen Y, Zhang Z, Shi X, Chen X, Zhu X, Hou B, Xing H, Xue H, Jin Z. Application of integrated positron emission tomography/magnetic resonance imaging in evaluating the prognostic factors of head and neck squamous cell carcinoma with positron emission tomography, diffusion-weighted imaging, dynamic contrast enhancement and combined model. Dentomaxillofac Radiol 2020;49:20190488. [PMID: 32202922 DOI: 10.1259/dmfr.20190488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Samolyk-Kogaczewska N, Sierko E, Dziemianczyk-Pakiela D, Nowaszewska KB, Lukasik M, Reszec J. Usefulness of Hybrid PET/MRI in Clinical Evaluation of Head and Neck Cancer Patients. Cancers (Basel) 2020;12:E511. [PMID: 32098356 DOI: 10.3390/cancers12020511] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
10 Samanci C, Onal Y, Sager S, Asa S, Ustabasioglu FE, Alis D, Akman C, Sonmezoglu K. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer. Curr Med Imaging Rev 2019;15:956-64. [PMID: 32008523 DOI: 10.2174/1573405614666180718124739] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Traylor KS, Koontz N, Mosier K. Squamous Cell Carcinoma: PET/CT and PET/MRI of the Pretreatment and Post-Treatment Neck. Seminars in Ultrasound, CT and MRI 2019;40:400-13. [DOI: 10.1053/j.sult.2019.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Paone G, Martucci F, Espeli V, Ceriani L, Treglia G, Ruberto T, Richetti A, Piantanida R, Giovanella L. 18F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging. Contrast Media Mol Imaging 2019;2019:4051206. [PMID: 31558887 DOI: 10.1155/2019/4051206] [Reference Citation Analysis]
13 Ryan JL, Aaron VD, Sims JB. PET/MRI vs PET/CT in Head and Neck Imaging: When, Why, and How? Semin Ultrasound CT MR 2019;40:376-90. [PMID: 31635765 DOI: 10.1053/j.sult.2019.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Klausner G, Troussier I, Blais E, Carsuzaa F, Zilli T, Miralbell R, Caparrotti F, Thariat J. Neck management in head and neck squamous cell carcinomas: where do we stand? Med Oncol 2019;36. [DOI: 10.1007/s12032-019-1265-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Kirchner J, Schaarschmidt BM, Sauerwein W, Deuschl C, Arweiler-Harbeck D, Holtmann L, Stebner V, Umutlu L, Antoch G, Ruhlmann V. 18 F-FDG PET/MRI vs MRI in patients with recurrent adenoid cystic carcinoma. Head Neck 2019;41:170-6. [PMID: 30548894 DOI: 10.1002/hed.25485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann RT, Zöphel K, Beuthien-Baumann B, Kotzerke J, van den Hoff J, Platzek I. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol 2019;29:422-8. [PMID: 29980927 DOI: 10.1007/s00330-018-5589-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
17 Galgano SJ, Marshall RV, Middlebrooks EH, Mcconathy JE, Bhambhvani P. PET/MR Imaging in Head and Neck Cancer. Magnetic Resonance Imaging Clinics of North America 2018;26:167-78. [DOI: 10.1016/j.mric.2017.08.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
18 Ma JT, Han CB, Zheng JH, Sun HZ, Zhang SM, Xin J, Guo QY. Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis. Nucl Med Commun 2017;38:642-9. [PMID: 28489688 DOI: 10.1097/MNM.0000000000000687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Nabavizadeh SA, Chawla S, Agarwal M, Mohan S. Chapter 8 On the Horizon: Advanced Imaging Techniques to Improve Noninvasive Assessment of Cervical Lymph Nodes. Semin Ultrasound CT MR 2017;38:542-56. [PMID: 29031370 DOI: 10.1053/j.sult.2017.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Kılıç S, Kılıç SS, Shah KP, Eloy JA, Baredes S, Mahmoud OM, Park RCW. Predictors of Clinicopathologic Stage Discrepancy in Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study. Otolaryngol Head Neck Surg 2018;158:309-18. [PMID: 29039250 DOI: 10.1177/0194599817736501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol 2018;73:60-9. [PMID: 29029767 DOI: 10.1016/j.crad.2017.09.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
22 Stumpp P, Purz S, Sabri O, Kahn T. [Molecular imaging of head and neck cancers : Perspectives of PET/MRI]. Radiologe 2016;56:588-96. [PMID: 27306200 DOI: 10.1007/s00117-016-0125-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
23 Jena A, Taneja S, Singh A, Negi P, Sarin R, Das PK, Singhal M. Reliability of 18F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study. AJR Am J Roentgenol 2017;209:662-70. [PMID: 28678576 DOI: 10.2214/AJR.16.17766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Ehman EC, Johnson GB, Villanueva-Meyer JE, Cha S, Leynes AP, Larson PEZ, Hope TA. PET/MRI: Where might it replace PET/CT? J Magn Reson Imaging. 2017;46:1247-1262. [PMID: 28370695 DOI: 10.1002/jmri.25711] [Cited by in Crossref: 75] [Cited by in F6Publishing: 100] [Article Influence: 15.0] [Reference Citation Analysis]
25 Roy S, Cheong DL, Yan J, Totman JJ, Ng T, Khor LK, Goh J, Tham IWK. Serial FDG-PET/MR Imaging for Head and Neck Cancer Radiation Therapy: A Pilot Study. IEEE Trans Radiat Plasma Med Sci 2017;1:158-63. [DOI: 10.1109/tns.2016.2616884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Sekine T, de Galiza Barbosa F, Kuhn FP, Burger IA, Stolzmann P, Huber GF, Kollias SS, von Schulthess GK, Veit-Haibach P, Huellner MW. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system. Clin Imaging 2017;42:232-9. [PMID: 28129606 DOI: 10.1016/j.clinimag.2017.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
27 Hempel JM, Kloeckner R, Krick S, Pinto Dos Santos D, Schadmand-Fischer S, Boeßert P, Bisdas S, Weber MM, Fottner C, Musholt TJ, Schreckenberger M, Miederer M. Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer. Cancer Imaging 2016;16:37. [PMID: 27809936 DOI: 10.1186/s40644-016-0096-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
28 Platzek I. 18F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer. PET Clinics 2016;11:375-86. [DOI: 10.1016/j.cpet.2016.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
29 Rasmussen JH, Nørgaard M, Hansen AE, Vogelius IR, Aznar MC, Johannesen HH, Costa J, Engberg AM, Kjær A, Specht L, Fischer BM. Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma. J Nucl Med 2017;58:69-74. [DOI: 10.2967/jnumed.116.180091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
30 Kim SG, Friedman K, Patel S, Hagiwara M. Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer. AJR Am J Roentgenol 2016;207:248-56. [PMID: 27163282 DOI: 10.2214/AJR.16.16265] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
31 Heuke S, Chernavskaia O, Bocklitz T, Legesse FB, Meyer T, Akimov D, Dirsch O, Ernst G, von Eggeling F, Petersen I, Guntinas-Lichius O, Schmitt M, Popp J. Multimodal nonlinear microscopy of head and neck carcinoma - toward surgery assisting frozen section analysis. Head Neck 2016;38:1545-52. [PMID: 27098552 DOI: 10.1002/hed.24477] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
32 Queiroz MA, Huellner MW. PET/MR in cancers of the head and neck. Semin Nucl Med. 2015;45:248-265. [PMID: 25841279 DOI: 10.1053/j.semnuclmed.2014.12.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
33 Hines JP, Howard BE, Hoxworth JM, Lal D. Positive and Negative Predictive Value of PET-CT in Skull Base Lesions: Case Series and Systematic Literature Review. J Neurol Surg Rep 2016;77:e39-45. [PMID: 26937333 DOI: 10.1055/s-0035-1570387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
34 Pujara AC, Raad RA, Ponzo F, Wassong C, Babb JS, Moy L, Melsaether AN. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT. Breast J 2016;22:264-73. [PMID: 26843433 DOI: 10.1111/tbj.12569] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
35 Chandra P, Purandare N, Shah S, Agrawal A, Rangarajan V. Common patterns of perineural spread in head-neck squamous cell carcinoma identified on fluoro-deoxy-glucose positron emission tomography/computed tomography. Indian J Nucl Med 2016;31:274-9. [PMID: 27833312 DOI: 10.4103/0972-3919.190798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
36 Nensa F, Beiderwellen K, Heusch P, Wetter A. Clinical applications of PET/MRI: current status and future perspectives. Diagn Interv Radiol 2014;20:438-47. [PMID: 25010371 DOI: 10.5152/dir.2014.14008] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 9.9] [Reference Citation Analysis]
37 Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schäfers M, Stegger L. [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2016;43:212-20. [DOI: 10.1007/s00259-015-3195-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
38 Gawlitza M, Purz S, Kubiessa K, Boehm A, Barthel H, Kluge R, Kahn T, Sabri O, Stumpp P. In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI. PLoS One. 2015;10:e0134749. [PMID: 26270054 DOI: 10.1371/journal.pone.0134749] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
39 Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Eur J Nucl Med Mol Imaging 2016;43:92-102. [PMID: 26243264 DOI: 10.1007/s00259-015-3145-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 8.3] [Reference Citation Analysis]
40 Bashir U, Mallia A, Stirling J, Joemon J, MacKewn J, Charles-Edwards G, Goh V, Cook GJ. PET/MRI in Oncological Imaging: State of the Art. Diagnostics (Basel) 2015;5:333-57. [PMID: 26854157 DOI: 10.3390/diagnostics5030333] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
41 Tudisca C, Nasoodi A, Fraioli F. PET-MRI: clinical application of the new hybrid technology. Nuclear Medicine Communications 2015;36:666-78. [DOI: 10.1097/mnm.0000000000000312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
42 Yang BY, Moon S, Seelam SR, Jeon MJ, Lee Y, Lee DS, Chung J, Kim YI, Jeong JM. Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging. Nanomedicine 2015;10:1899-910. [DOI: 10.2217/nnm.15.41] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
43 Brendle C, Schmidt H, Oergel A, Bezrukov I, Mueller M, Schraml C, Pfannenberg C, la Fougère C, Nikolaou K, Schwenzer N. Segmentation-Based Attenuation Correction in Positron Emission Tomography/Magnetic Resonance: Erroneous Tissue Identification and Its Impact on Positron Emission Tomography Interpretation. Investigative Radiology 2015;50:339-46. [DOI: 10.1097/rli.0000000000000131] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
44 Covello M, Cavaliere C, Aiello M, Cianelli MS, Mesolella M, Iorio B, Rossi A, Nicolai E. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation. Eur J Radiol. 2015;84:1269-1276. [PMID: 25958189 DOI: 10.1016/j.ejrad.2015.04.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
45 Ladefoged CN, Hansen AE, Keller SH, Fischer BM, Rasmussen JH, Law I, Kjær A, Højgaard L, Lauze F, Beyer T, Andersen FL. Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR. EJNMMI Phys 2015;2:8. [PMID: 26501810 DOI: 10.1186/s40658-015-0112-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
46 Rasmussen JH, Fischer BM, Aznar MC, Hansen AE, Vogelius IR, Löfgren J, Andersen FL, Loft A, Kjaer A, Højgaard L, Specht L. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR. Br J Radiol 2015;88:20140655. [PMID: 25634069 DOI: 10.1259/bjr.20140655] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
47 Yoo HJ, Lee JS, Lee JM. Integrated whole body MR/PET: where are we? Korean J Radiol 2015;16:32-49. [PMID: 25598673 DOI: 10.3348/kjr.2015.16.1.32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
48 Loeffelbein DJ, Souvatzoglou M, Wankerl V, Dinges J, Ritschl LM, Mücke T, Pickhard A, Eiber M, Schwaiger M, Beer AJ. Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancer. BMC Cancer 2014;14:846. [PMID: 25407100 DOI: 10.1186/1471-2407-14-846] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
49 Partovi S, Kohan A, Vercher-Conejero JL, Rubbert C, Margevicius S, Schluchter MD, Gaeta C, Faulhaber P, Robbin MR. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer. AJNR Am J Neuroradiol 2014;35:1970-5. [PMID: 24924545 DOI: 10.3174/ajnr.A3993] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
50 Blanchet EM, Millo C, Martucci V, Maass-Moreno R, Bluemke DA, Pacak K. Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol. Clin Nucl Med 2014;39:243-50. [PMID: 24152658 DOI: 10.1097/RLU.0000000000000289] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
51 Navaie M, Sharghi LH, Cho-reyes S, Keefe MA, Howie BA, Setzen G. Diagnostic Approach, Treatment, and Outcomes of Cervical Sympathetic Chain Schwannomas: A Global Narrative Review. Otolaryngol Head Neck Surg 2014;151:899-908. [DOI: 10.1177/0194599814549550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
52 Purohit BS, Ailianou A, Dulguerov N, Becker CD, Ratib O, Becker M. FDG-PET/CT pitfalls in oncological head and neck imaging. Insights Imaging 2014;5:585-602. [PMID: 25154759 DOI: 10.1007/s13244-014-0349-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 88] [Article Influence: 11.9] [Reference Citation Analysis]
53 Eldib M, Bini J, Calcagno C, Robson PM, Mani V, Fayad ZA. Attenuation correction for flexible magnetic resonance coils in combined magnetic resonance/positron emission tomography imaging. Invest Radiol 2014;49:63-9. [PMID: 24056110 DOI: 10.1097/RLI.0b013e3182a530f8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
54 Queiroz MA, Hüllner M, Kuhn F, Huber G, Meerwein C, Kollias S, von Schulthess G, Veit-haibach P. Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation. Eur J Nucl Med Mol Imaging 2014;41:2212-21. [DOI: 10.1007/s00259-014-2867-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
55 Platzek I, Beuthien-baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, Schramm G, Popp M, Laniado M, Kotzerke J, van den Hoff J. FDG PET/MR for lymph node staging in head and neck cancer. European Journal of Radiology 2014;83:1163-8. [DOI: 10.1016/j.ejrad.2014.03.023] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
56 Beiderwellen K, Huebner M, Heusch P, Grueneisen J, Ruhlmann V, Nensa F, Kuehl H, Umutlu L, Rosenbaum-krumme S, Lauenstein TC. Whole-body [18F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results. Eur Radiol 2014;24:2023-30. [DOI: 10.1007/s00330-014-3229-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
57 Schmidt H, Schwenzer NF, Bezrukov I, Mantlik F, Kolb A, Kupferschläger J, Pichler BJ. On the Quantification Accuracy, Homogeneity, and Stability of Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging Systems: . Investigative Radiology 2014;49:373-81. [DOI: 10.1097/rli.0000000000000021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
58 Iannessi A, Ouvrier MJ, Thariat J, Marcy P. Imagerie des cancers ORL. Bulletin du Cancer 2014;101:469-80. [DOI: 10.1684/bdc.2014.1967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
59 Zhang S, Xin J, Guo Q, Ma J, Ma Q, Sun H. Comparison of Tumor Volume Between PET and MRI in Cervical Cancer With Hybrid PET/MR. Int J Gynecol Cancer 2014;24:744-50. [DOI: 10.1097/igc.0000000000000097] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
60 Tian J, Fu L, Yin D, Zhang J, Chen Y, An N, Xu B. Does the novel integrated PET/MRI offer the same diagnostic performance as PET/CT for oncological indications? PLoS One 2014;9:e90844. [PMID: 24603857 DOI: 10.1371/journal.pone.0090844] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
61 Queiroz MA, Hüllner M, Kuhn F, Huber G, Meerwein C, Kollias S, von Schulthess G, Veit-Haibach P. PET/MRI and PET/CT in follow-up of head and neck cancer patients. Eur J Nucl Med Mol Imaging 2014;41:1066-75. [PMID: 24577950 DOI: 10.1007/s00259-014-2707-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
62 Becker M, Zaidi H. Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI. Br J Radiol 2014;87:20130677. [PMID: 24649835 DOI: 10.1259/bjr.20130677] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 7.4] [Reference Citation Analysis]
63 Lee SJ, Seo HJ, Cheon GJ, Kim JH, Kim EE, Kang KW, Paeng JC, Chung JK, Lee DS. Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study. Nucl Med Mol Imaging. 2014;48:98-105. [PMID: 24900149 DOI: 10.1007/s13139-013-0252-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
64 Kubiessa K, Purz S, Gawlitza M, Kühn A, Fuchs J, Steinhoff KG, Boehm A, Sabri O, Kluge R, Kahn T, Stumpp P. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 2014;41:639-48. [DOI: 10.1007/s00259-013-2633-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
65 de Bree R. Functional imaging to predict treatment response after (chemo) radiotherapy of head and neck squamous cell carcinoma. Quant Imaging Med Surg 2013;3:231-4. [PMID: 24273739 DOI: 10.3978/j.issn.2223-4292.2013.10.01] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
66 Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol 2014;83:289-96. [PMID: 24331845 DOI: 10.1016/j.ejrad.2013.11.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 11.3] [Reference Citation Analysis]
67 Fraioli F, Punwani S. Clinical and research applications of simultaneous positron emission tomography and MRI. Br J Radiol 2014;87:20130464. [PMID: 24234585 DOI: 10.1259/bjr.20130464] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
68 Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, Saito M, Otsuki N, Nibu K, Sugimura K. Value of retrospective image fusion of 18F-FDG PET and MRI for preoperative staging of head and neck cancer: Comparison with PET/CT and contrast-enhanced neck MRI. European Journal of Radiology 2013;82:2005-10. [DOI: 10.1016/j.ejrad.2013.06.025] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
69 Varoquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 2014;41:462-75. [PMID: 24108458 DOI: 10.1007/s00259-013-2580-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 8.3] [Reference Citation Analysis]
70 Tateishi U. PET/CT in malignant lymphoma: basic information, clinical application, and proposal. Int J Hematol 2013;98:398-405. [DOI: 10.1007/s12185-013-1444-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Partovi S, Robbin MR, Steinbach OC, Kohan A, Rubbert C, Vercher-Conejero JL, Kolthammer JA, Faulhaber P, Paspulati RM, Ros PR. Initial experience of MR/PET in a clinical cancer center. J Magn Reson Imaging. 2014;39:768-780. [PMID: 24006287 DOI: 10.1002/jmri.24334] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
72 Herrmann KA, Kohan AA, Gaeta MC, Rubbert C, Vercher-conejero JL, Paspulati RM, Antonis K, Mansoori B, Faulhaber PF, Avril N, Ros PR. PET/MRI: Applications in Clinical Imaging. Curr Radiol Rep 2013;1:161-76. [DOI: 10.1007/s40134-013-0021-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Jadvar H, Colletti PM. Competitive advantage of PET/MRI. Eur J Radiol. 2014;83:84-94. [PMID: 23791129 DOI: 10.1016/j.ejrad.2013.05.028] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 11.1] [Reference Citation Analysis]
74 Littooij AS, Torigian DA, Kwee TC, de Keizer B, Alavi A, Nievelstein RA. Potential Clinical Applications of PET/Magnetic Resonance Imaging. PET Clin 2013;8:367-84. [PMID: 27158074 DOI: 10.1016/j.cpet.2013.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Kohan AA, Vercher Conejero JL, Gaeta MC, Pelegrí Martinez L, Ros PR. [Positron emission tomography/magnetic resonance: Present and future]. Rev Esp Med Nucl Imagen Mol 2013;32:167-76. [PMID: 23582491 DOI: 10.1016/j.remn.2013.01.004] [Reference Citation Analysis]
76 Pace L, Nicolai E, Aiello M, Catalano OA, Salvatore M. Whole-body PET/MRI in oncology: current status and clinical applications. Clin Transl Imaging 2013;1:31-44. [DOI: 10.1007/s40336-013-0012-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]